lumiliximab monoclonal antibody targets acts awarded orphan drug status fast track designation investigated phase iiiii clinical trials treatment chronic lymphocytic also studied use allergic asthma drug chimeric antibody macaca irus homo lumiliximab developed idec pharmaceuticals acquired biogen clinical trials cll terminated allergic asthma results published cll clinical trial failed meet primary immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikilumiliximab